{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:34:47Z","timestamp":1793003687521,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Research Hospital Program of the Jiangsu Provincial Health Commission","award":["No. YJXYY202204"],"award-info":[{"award-number":["No. YJXYY202204"]}],"id":[{"id":"https:\/\/ror.org\/03eqskn19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13402-026-01291-6","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:44:16Z","timestamp":1788572656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DPP9 modulates RPA1 stability and temozolomide sensitivity through RFWD3 Nuclear localization in glioma"],"prefix":"10.1007","volume":"49","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"issue":"1","key":"1291_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"M. Weller, P.Y. Wen, S.M. Chang, L. Dirven, M. Lim, M. Monje et al., Glioma Nat. Rev. Dis. Primers. 10(1), 33 (2024)","journal-title":"Glioma Nat. Rev. Dis. Primers"},{"issue":"7120","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444(7120), 756\u2013760 (2006)","journal-title":"Nature"},{"key":"1291_CR3","doi-asserted-by":"crossref","unstructured":"M. Wang, S. Chen, D. Ao, Targeting DNA repair pathway in cancer: Mechanisms and clinical application. MedComm (2020). 2021;2(4):654\u2009\u2013\u200991","DOI":"10.1002\/mco2.103"},{"issue":"7","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-024-00967-7","volume":"20","author":"R Rud\u00e0","year":"2024","unstructured":"R. Rud\u00e0, C. Horbinski, van den M. Bent, M. Preusser, R. Soffietti, IDH inhibition in gliomas: from preclinical models to clinical trials. Nat. Rev. Neurol. 20(7), 395\u2013407 (2024)","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"1291_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI89587","volume":"127","author":"S Osuka","year":"2017","unstructured":"S. Osuka, Van E.G. Meir, Overcoming therapeutic resistance in glioblastoma: the way forward. J. Clin. Invest. 127(2), 415\u2013426 (2017)","journal-title":"J. Clin. Invest."},{"key":"1291_CR6","doi-asserted-by":"publisher","first-page":"107922","DOI":"10.1016\/j.pharmthera.2021.107922","volume":"228","author":"F Lang","year":"2021","unstructured":"F. Lang, Y. Liu, F.J. Chou, C. Yang, Genotoxic therapy and resistance mechanism in gliomas. Pharmacol. Ther. 228, 107922 (2021)","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"1291_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13402-026-01167-9","volume":"49","author":"A Kuerban","year":"2026","unstructured":"A. Kuerban, L. Xie, M. He, M. Luo, L. Ouyang, D. Yin et al., CSRP2 modulates PDGFRA\/PI3K\/AKT signaling via PRC1 components in glioma. Cell. Oncol. 49(1), 42 (2026)","journal-title":"Cell. Oncol."},{"key":"1291_CR8","doi-asserted-by":"publisher","first-page":"217684","DOI":"10.1016\/j.canlet.2025.217684","volume":"620","author":"C Cheng","year":"2025","unstructured":"C. Cheng, L. Cui, X. Cui, Q. Zhan, J. Ju, B. Hong et al., ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-\u03b1 - NF-\u03baB pathway. Cancer Lett. 620, 217684 (2025)","journal-title":"Cancer Lett."},{"issue":"1","key":"1291_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-025-07509-z","volume":"16","author":"E Duplan","year":"2025","unstructured":"E. Duplan, A. Bernardin, T. Goiran, N. Leroudier, M. Casimiro, R. Pestell et al., \u03b1-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance. Cell. Death Dis. 16(1), 188 (2025)","journal-title":"Cell. Death Dis."},{"issue":"4","key":"1291_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1172\/JCI43976","volume":"121","author":"CM Connell","year":"2011","unstructured":"C.M. Connell, A. Shibata, L.A. Tookman, K.M. Archibald, M.B. Flak, K.J. Pirlo et al., Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells. J. Clin. Invest. 121(4), 1283\u20131297 (2011)","journal-title":"J. Clin. Invest."},{"issue":"8","key":"1291_CR11","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.ccell.2025.06.011","volume":"43","author":"A Galan-Cobo","year":"2025","unstructured":"A. Galan-Cobo, N.I. Vokes, Y. Qian, D. Molkentine, K. Ramkumar, A.G. Paula et al., KEAP1 and STK11\/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer. Cancer Cell. 43(8), 1530\u201348e9 (2025)","journal-title":"Cancer Cell."},{"issue":"6","key":"1291_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"A.N. Blackford, S.P. Jackson, ATM, ATR, The Trinity at the Heart of the DNA Damage Response. Mol. Cell. 66(6), 801\u2013817 (2017)","journal-title":"Mol. Cell."},{"key":"1291_CR13","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1038\/ncomms5901","volume":"5","author":"M Wang","year":"2014","unstructured":"M. Wang, L. Guo, Q. Wu, T. Zeng, Q. Lin, Y. Qiao et al., ATR\/Chk1\/Smurf1 pathway determines cell fate after DNA damage by controlling RhoB abundance. Nat. Commun. 5, 4901 (2014)","journal-title":"Nat. Commun."},{"issue":"2","key":"1291_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13402-024-01007-8","volume":"48","author":"K Malone","year":"2025","unstructured":"K. Malone, E. LaCasse, S.T. Beug, Cell death in glioblastoma and the central nervous system. Cell. Oncol. 48(2), 313\u2013349 (2025)","journal-title":"Cell. Oncol."},{"issue":"6605","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1126\/science.abn7570","volume":"377","author":"K Lin","year":"2022","unstructured":"K. Lin, S.E. Gueble, R.K. Sundaram, E.D. Huseman, R.S. Bindra, S.B. Herzon, Mechanism-based design of agents that selectively target drug-resistant glioma. Science. 377(6605), 502\u2013511 (2022)","journal-title":"Science"},{"issue":"23","key":"1291_CR16","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"K. Chang, Y. Chen, X. Zhang, W. Zhang, N. Xu, B. Zeng et al., DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma. Cancer Res. 83(23), 3940\u20133955 (2023)","journal-title":"Cancer Res."},{"issue":"75","key":"1291_CR17","doi-asserted-by":"publisher","first-page":"eabi4611","DOI":"10.1126\/sciimmunol.abi4611","volume":"7","author":"CR Harapas","year":"2022","unstructured":"C.R. Harapas, K.S. Robinson, K. Lay, J. Wong, R. Moreno Traspas, N. Nabavizadeh et al., DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1\/IL-1 signaling. Sci. Immunol. 7(75), eabi4611 (2022)","journal-title":"Sci. Immunol."},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"103292","DOI":"10.1016\/j.redox.2024.103292","volume":"75","author":"Y Zhou","year":"2024","unstructured":"Y. Zhou, Y. Chen, C. Xuan, X. Li, Y. Tan, M. Yang et al., DPP9 regulates NQO1 and ROS to promote resistance to chemotherapy in liver cancer cells. Redox Biol. 75, 103292 (2024)","journal-title":"Redox Biol."},{"issue":"10","key":"1291_CR19","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1093\/nar\/gkv369","volume":"43","author":"A Kar","year":"2015","unstructured":"A. Kar, M. Kaur, T. Ghosh, M.M. Khan, A. Sharma, R. Shekhar et al., RPA70 depletion induces hSSB1\/2-INTS3 complex to initiate ATR signaling. Nucleic Acids Res. 43(10), 4962\u20134974 (2015)","journal-title":"Nucleic Acids Res."},{"issue":"34","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"eadw2756","DOI":"10.1126\/sciadv.adw2756","volume":"11","author":"Q Yin","year":"2025","unstructured":"Q. Yin, S. Peng, Z. Zhang, S. Jiang, X. Li, D. Huang et al., RPA1 protects DNA damage-induced PANoptosis in limb development. Sci. Adv. 11(34), eadw2756 (2025)","journal-title":"Sci. Adv."},{"issue":"5","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2005.12.041","volume":"124","author":"A Kumagai","year":"2006","unstructured":"A. Kumagai, J. Lee, H.Y. Yoo, W.G. Dunphy, TopBP1 activates the ATR-ATRIP complex. Cell. 124(5), 943\u2013955 (2006)","journal-title":"Cell"},{"issue":"11","key":"1291_CR22","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41590-024-01988-6","volume":"25","author":"C Shen","year":"2024","unstructured":"C. Shen, A. Pandey, D. Enosi Tuipulotu, A. Mathur, L. Liu, H. Yang et al., Inflammasome protein scaffolds the DNA damage complex during tumor development. Nat. Immunol. 25(11), 2085\u20132096 (2024)","journal-title":"Nat. Immunol."},{"issue":"5","key":"1291_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molcel.2017.04.022","volume":"66","author":"S Inano","year":"2017","unstructured":"S. Inano, K. Sato, Y. Katsuki, W. Kobayashi, H. Tanaka, K. Nakajima et al., RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination. Mol. Cell. 66(5), 622\u201334e8 (2017)","journal-title":"Mol. Cell."},{"issue":"1","key":"1291_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molcel.2020.03.026","volume":"78","author":"S Inano","year":"2020","unstructured":"S. Inano, K. Sato, Y. Katsuki, W. Kobayashi, H. Tanaka, K. Nakajima et al., RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination. Mol. Cell. 78(1), 192 (2020)","journal-title":"Mol. Cell."},{"key":"1291_CR25","doi-asserted-by":"crossref","unstructured":"C.E. Moore, S.E. Yalcindag, H. Czeladko, R. Ravindranathan, Y. Wijesekara Hanthi, J.C. Levy et al., RFWD3 promotes ZRANB3 recruitment to regulate the remodeling of stalled replication forks. J. Cell. Biol. 2023;222(5)","DOI":"10.1083\/jcb.202106022"},{"issue":"3","key":"1291_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.molcel.2020.11.029","volume":"81","author":"I Gallina","year":"2021","unstructured":"I. Gallina, I.A. Hendriks, S. Hoffmann, N.B. Larsen, J. Johansen, C.S. Colding-Christensen et al., The ubiquitin ligase RFWD3 is required for translesion DNA synthesis. Mol. Cell. 81(3), 442\u201358e9 (2021)","journal-title":"Mol. Cell."},{"issue":"2","key":"1291_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2015.09.011","volume":"60","author":"AE Elia","year":"2015","unstructured":"A.E. Elia, D.C. Wang, N.A. Willis, A.P. Boardman, I. Hajdu, R.O. Adeyemi et al., RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks. Mol. Cell. 60(2), 280\u2013293 (2015)","journal-title":"Mol. Cell."},{"issue":"1","key":"1291_CR28","doi-asserted-by":"publisher","first-page":"11029","DOI":"10.1038\/s41467-025-66068-1","volume":"16","author":"KE Coleman","year":"2025","unstructured":"K.E. Coleman, D.W. Shin, L. Goehring, B. Szeitz, D. Feny\u00f6, E. Rothenberg et al., SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress. Nat. Commun. 16(1), 11029 (2025)","journal-title":"Nat. Commun."},{"issue":"5","key":"1291_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2017.04.021","volume":"66","author":"L Feeney","year":"2017","unstructured":"L. Feeney, I.M. Mu\u00f1oz, C. Lachaud, R. Toth, P.L. Appleton, D. Schindler et al., RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health. Mol. Cell. 66(5), 610\u201321e4 (2017)","journal-title":"Mol. Cell."},{"issue":"48","key":"1291_CR30","doi-asserted-by":"publisher","first-page":"e08481","DOI":"10.1002\/advs.202508481","volume":"12","author":"XY Shi","year":"2025","unstructured":"X.Y. Shi, Y.K. Shen, M.Y. Lv, Y. Sun, Y.F. Lin, Z. Wang et al., Smohaze-Upregulated RFWD3 Competes with TRIM24 to Stabilize TREX1 and Reduce Cytosolic dsDNA in Non-Small Cell Lung Cancer. Adv. Sci. (Weinh). 12(48), e08481 (2025)","journal-title":"Adv. Sci. (Weinh)"},{"issue":"21","key":"1291_CR31","doi-asserted-by":"publisher","first-page":"eadk8908","DOI":"10.1126\/sciadv.adk8908","volume":"10","author":"J Ma","year":"2024","unstructured":"J. Ma, D. Ren, Z. Wang, W. Li, L. Li, T. Liu et al., CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. Sci. Adv. 10(21), eadk8908 (2024)","journal-title":"Sci. Adv."},{"issue":"27","key":"1291_CR32","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/s41388-025-03409-w","volume":"44","author":"W Wu","year":"2025","unstructured":"W. Wu, W. Wu, X. Xie, J. Li, Y. Gao, L. Xie et al., DNMT1 is required for efficient DSB repair and maintenance of replication fork stability, and its loss reverses resistance to PARP inhibitors in cancer cells. Oncogene. 44(27), 2283\u20132302 (2025)","journal-title":"Oncogene"},{"issue":"2","key":"1291_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7150\/thno.88899","volume":"14","author":"X Sun","year":"2024","unstructured":"X. Sun, M. Dong, J. Li, Y. Sun, Y. Gao, Y. Wang et al., NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway. Theranostics. 14(2), 681\u2013698 (2024)","journal-title":"Theranostics"},{"issue":"3","key":"1291_CR34","doi-asserted-by":"publisher","first-page":"e3002552","DOI":"10.1371\/journal.pbio.3002552","volume":"22","author":"M Yates","year":"2024","unstructured":"M. Yates, I. Marois, E. St-Hilaire, D.A. Ronato, B. Djerir, C. Brochu et al., SMARCAL1 ubiquitylation controls its association with RPA-coated ssDNA and promotes replication fork stability. PLoS Biol. 22(3), e3002552 (2024)","journal-title":"PLoS Biol."},{"issue":"1","key":"1291_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","volume":"22","author":"A da Costa","year":"2023","unstructured":"da A. Costa, D. Chowdhury, G.I. Shapiro, A.D. D\u2019Andrea, P.A. Konstantinopoulos, Targeting replication stress in cancer therapy. Nat. Rev. Drug Discov. 22(1), 38\u201358 (2023)","journal-title":"Nat. Rev. Drug Discov"},{"issue":"12","key":"1291_CR36","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"S. Saxena, L. Zou, Hallmarks of DNA replication stress. Mol. Cell. 82(12), 2298\u20132314 (2022)","journal-title":"Mol. Cell."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01291-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:06:22Z","timestamp":1793001982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01291-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01291-6","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Ethics Committee of the Affiliated Hospital of Nantong University (Approval Number: 2018-K020). All human tissue collection and research procedures were performed in strict compliance with the ethical guidelines of the institutional review board and the updated Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"139"}}